| |
Home : I : Ibutilide Fumarate : Moxifloxacin HCl and Ibutilide Fumarate
Effects and Recommendation :
Resulting In: Torsades de pointes Use of Moxifloxacin HCl with Ibutilide Fumarate may increase the risk of life-threatening cardiac arrhythmias, including torsades de pointes.
MOXIFLOXACIN is contraindicated in patients receiving GROUP Ia and GROUP III ANTIARRHYTHMICS.
Severity of the interaction : 6/6
|
Information on this interaction is found in the following publications :
----------
Product Information. Moxifloxacin (Avelox). Bayer, December 1999.
Publication : Moxifloxacin (Avelox) by Product Information
> Product Information - -
|
|
|
|
|
